[HTML][HTML] A study of the assessment of pathological response to neoadjuvant chemotherapy in patients with breast cancer
S Mallige, A Ananthamurthy… - Annals of Oncology …, 2024 - journals.lww.com
BACKGROUND: Neoadjuvant chemotherapy therapy (NACT) has emerged as an integrated
therapeutic approach to treat locally advanced breast cancer in order to down stage the …
therapeutic approach to treat locally advanced breast cancer in order to down stage the …
[HTML][HTML] A new pathological assessment method to assess residual lesions after neoadjuvant chemotherapy for breast cancer, residual disease in breast and nodes …
R Han, Y Ma, Z Liu, C Li, S Li, X Kong… - Translational Breast …, 2022 - ncbi.nlm.nih.gov
Background The accurate assessment of residual tumor tissue after neoadjuvant
chemotherapy (NAC) for breast cancer is closely related to the subsequent treatment and …
chemotherapy (NAC) for breast cancer is closely related to the subsequent treatment and …